06/01216.11/2026 - Acquisition of the medication "Asciminib 40 mg tablets" under Framework Agreement 2024/961 (CC2026)
About This Opportunity
TranslatedThis tender, reference 06/01216.11/2026, concerns the acquisition of the specific medication "Asciminib 40 mg tablets". The procurement is being conducted under the existing Framework Agreement 2024/961, identified as CC2026. This indicates that the terms and conditions for the supply of this medication have been pre-negotiated. The objective is to secure a supply of Asciminib, a targeted therapy drug, likely for oncological treatments. The tender process will focus on selecting a supplier from the framework agreement participants who can best meet the demand for this specific pharmaceutical product, ensuring its availability for patients. This approach streamlines the procurement of specialized medicines.
This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 40,000.
Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: Portuguese06/01216.11/2026 - Aquisição do medicamento "Asciminib 40 mg comp" ao abrigo do Acordo Quadro 2024/961 (CC2026)
Data provenance
This notice is sourced from base_gov_pt and was originally published on March 30, 2026. Last refreshed 4 days ago. Original language: Portuguese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E
Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E has issued 580 procurement notices on BidsFactory, including 0 currently open and 567 awarded contracts. Activity concentrates in General Supplies & Services, Health & Medical, and Information & Communication Technology. All notices are published for Portugal. Notices are distributed via base_gov_pt. Most recent publication: June 18, 2026.
Frequently asked questions about this tender
Where will the contract be performed?
The contract is for delivery in Portugal. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit base_gov_pt to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to NOVARTIS FARMACEUTICA. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Unidade Local de Saúde de Entre O Douro e Vouga, E.P.E in Portugal. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
What type of contract is this?
This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
What is the estimated budget?
The estimated contract value is €40,000 - €40,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.